One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Plaquenil doses lupus Hydroxychloroquine eye damage AAO 2020 paper/poster and video abstracts are accepted March 12 - April 14, 2020. View. APR 22. Canceled Mid-Year Forum 2020 Renaissance Downtown, Washington, D. C. This annual forum provides an opportunity for Academy members, leaders and leaders of allied ophthalmic organizations to identify and discuss critical issues facing ophthalmology. Optical Coherence Tomography Protocols for Screening of Hydroxychloroquine Retinopathy in Asian Patients. Am J Ophthalmol. 2017 Sep 27. Guideline AAO Quality of Care Secretariat, Hoskins Center for Quality Eye Care. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy - 2016. American Academy of Ophthalmology. The American Academy of Ophthalmology has published several dosing and screening recommendations for hydroxychloroquine to avoid potential retinal toxicity, yet some patients still experience. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Plaquenil screening guidelines aao Quick Reference Screening for Chloroquine., Chloroquine and Hydroxychloroquine Toxicity Guidelines. Chloroquine autophagyMacular oct plaquenil toxicitySeroquel and plaquenil interactionsHydroxychloroquine vs chloroquine INTRODUCTION Recommendations for screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy have recently been changed by the American Academy of Ophthalmology, taking into account new published data on toxicity prevalence, risk factors, location of onset in the retina and the efficacy of screening tests. METHODS Literature review. Update on recommendations for screening for.. Despite Plaquenil dosing recommendations, retinal toxicity.. Rx Side Effects New Plaquenil Guidelines and More.. Aug 30, 2011 Newer guidelines state that daily dose 5mg/kg of real weight/day can lead to toxicity. Retinal toxicity is irreversible and can progress after cessation of hydroxychloroquine, thus early screening is important to limit potential vision loss. Baseline screening and annual screening after five years is recommended. In 2011, the AAO published updated ocular examination guidelines for screening patients on Plaquenil therapy. 4 Recommended testing includes a comprehensive eye exam with an assessment of posterior segment via dilated funduscopy. Testing for Chloroquine and Hydroxychloroquine Retinopathy. Introduction Although the exact mechanism by which chloroquine CQ and hydroxychloroquine HCQ - commonly known as Plaquenil induce retinal toxicity is not well understood, but it is recognized as a serious ophthalmologic concern because it is not treatable. 1 Guidelines from the American Academy of Ophthalmology AAO on screening.